Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Immunotherapy drug effective for metastatic triple negative breast cancer

Science Daily - 4 Jun 2017 19:58
The immunotherapy drug, Pembrolizumab, is effective in shrinking tumors among metastatic triple negative breast cancer patients as found in a clinical trial.
Full Article at Science Daily

More Science News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard